This brand name is authorized in Austria, Cyprus, France, Netherlands, New Zealand
The drug ASPRO contains one active pharmaceutical ingredient (API):
|
1
Acetylsalicylic acid
UNII R16CO5Y76E - ASPIRIN
|
|
Acetylsalicylic acid combines significant advantages such as strong anti-pyretic, analgesic and anti-inflammatory action, that is the measure of comparison with all the newer NSAIDs. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02BA01 | Acetylsalicylic acid | N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BA Salicylic acid and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 64647032, 68985138 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 3972 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 138, 139, 8255 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
